New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
iRhythm Technologies, Inc.
IRTC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

2B

Medical - Devices

Next Earning date - 30 Oct 2024

2B

Medical - Devices

Next Earning date - 30 Oct 2024

75.68USD
Shape-2.44 ( -3.12%)
favorite-chart

Relative Strenght

15
favorite-chart

Volume Buzz

-20%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

39%

Quote Panel

Shape
Updated October 27, 2024
1W 21.87 % 1M 1.94 % 3M -14.55 % 1Y -1.48 %

Key Metrics

Shape
  • Market Cap

    2.36B


  • Shares Outstanding

    31.24M


  • Share in Float

    30.72M


  • Dividende

    0


  • Earning Date

    30 Oct 2024


  • Price Target

    75.68


  • Average Volume

    601004


  • Beta

    1.219


  • Range

    55.92-124.115


  • Industry

    Medical - Devices


  • Website

    https://www.irhythmtech.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

4.40x

P/S Ratio

23.76x

P/B Ratio

6.7

Debt/Equity

-24.5%

Net Margin

$-4.3

EPS

How IRTC compares to sector?

P/E Ratio

Relative Strength

Shape

IRTC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$691M

Shape367%

2025-Revenue

$1.89

Shape-191%

2025-EPS

$153M

Shape-824%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Goldman Sachs

initialise

Previous: Not converted

2024-10-04

Now: Neutral

Wolfe Research

upgrade

Previous: Not converted

2024-06-20

Now: Outperform

BTIG

initialise

Previous: Buy

2023-02-07

Now: Neutral

UBS

initialise

Previous: Not converted

2023-02-07

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.63
vs -0.81

Q4.22

arrow
arrow

N/A

-0.67
vs -1.10

Q1.23

arrow
arrow

N/A

-1.29
vs -0.80

Q2.23

arrow
arrow

N/A

-0.61
vs -0.79

Q3.23

arrow
arrow

N/A

-0.89
vs -0.63

Q4.23

arrow
arrow

N/A

-1.26
vs -0.67

Q1.24

arrow
arrow

N/A

-1.47
vs -1.29

Q2.24

arrow
arrow

N/A

-0.61
vs -0.61

Q3.24

arrow
arrow

N/A

-0.58
vs -0.89

Q4.24

arrow
arrow

N/A

-0.32
vs -1.26

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+22%

103.9M  vs 85.4M

Q4.22

arrow
arrow

+38%

112.6M  vs 81.8M

Q1.23

arrow
arrow

+21%

111.4M  vs 92.4M

Q2.23

arrow
arrow

+22%

124.1M  vs 102.1M

Q3.23

arrow
arrow

+20%

124.6M  vs 103.9M

Q4.23

arrow
arrow

+18%

132.5M  vs 112.6M

Q1.24

arrow
arrow

+18%

131.9M  vs 111.4M

Q2.24

arrow
arrow

+19%

148M  vs 124.1M

Q3.24

arrow
arrow

+18%

146.7M  vs 124.6M

Q4.24

arrow
arrow

+20%

158.4M  vs 132.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-9%

-0.09
vs -0.10

Q4.22

arrow
arrow

-8%

-0.08
vs -0.09

Q1.23

arrow
arrow

-18%

-0.18
vs -0.08

Q2.23

arrow
arrow

-8%

-0.08
vs -0.18

Q3.23

arrow
arrow

-12%

-0.12
vs -0.08

Q4.23

arrow
arrow

-18%

-0.18
vs -0.12

Q1.24

arrow
arrow

-51%

-0.51
vs -0.18

Q2.24

arrow
arrow

-20%

-0.20
vs -0.51

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

245

245
vs 252

-3%

Q4.22

arrow
arrow

218

218
vs 245

-11%

Q1.23

arrow
arrow

224

224
vs 218

3%

Q2.23

arrow
arrow

216

216
vs 224

-4%

Q3.23

arrow
arrow

244

244
vs 216

13%

Q4.23

arrow
arrow

237

237
vs 244

-3%

Q1.24

arrow
arrow

268

268
vs 237

13%

Q2.24

arrow
arrow

240

240
vs 268

-10%

Earnings Growth

Latest News